Skip to main content
. 2022 May 11;93(2):e2022022. doi: 10.23750/abm.v93i2.10736

Table 4.

Standard two dimensional echocardiographic measurements and Z scores at baseline and at the end of the study

Characteristic MeanBaseline (B) Group 1 (N: 17) (1) Group 2 (N: 15) (2) P-value 1,2 1,B 2,B
LVIDd (mm)
LVIDd/BSA
LVIDd (Z score)
40.4 ± 4.6
40.2 ± 8.4
- 0.03 ± 0.9
40.9± 12.3
38.6 ± 8.2
0.46 ± 0.9
43.8 ± 7.8
46.2±16.6
0.91 ± 1.4
1.00
0.35
1.00
1.00
0.56
1.00
0.37
1.00
0.62
LVISd (mm)
LVISd/BSA
LVISd(Z score)
25.1 ± 4.8
25.0 ± 6.1
0.04 ± 0.9
27.2 ± 4.8
23.9 ± 5.6
0.2 ± 1.0
28 ± 7.0
28.9±10.5
0.91 ± 1.4
1.00
0.37
0.21
0.71
0.61
0.21
0.55
1.00
1.00
IVSd (mm)
IVSd/BSA
IVSd (Z score)
5.6 ± 1.3
5.5 ± 1.6
-0.5 ± 1.1
7.0 ± 1.5
6.2 ± 1.9
0.4 ± 0.9
6.1± 2.5
5.9 ± 1.8
0.0026±1.3
0.77
1.00
1.00
1.00
1.00
1.00
0.07
0.78
0.07
LVPWd (mm)
LVPWd/BSA
LVPWd(Zscore)
5.0 ± 0.9
4.9 ± 0.9
-0.6 ± 0.6
5.9 ± 1.3
5.2 ± 1.2
0.01 ± 1.0
5.4 ± 2.2
5.4 ± 2.2
0.1 ± 1.6
1.00
1.00
1.00
1.00
1.00
0.36
0.24
1.00
0.34
EF (%) 68.0 ± 7.3 68.0 ± 7.5 69 ± 8.3 1.00 1.00 1.00
SF (%) 37.9 ± 6.1 38.0 ± 5.8 38 ± 7 1.00 1.00 1.00
AoAn(mm)
AoAn/BSA
AoAn(Z score)
16.3 ± 2.1
16.0 ± 2.7
0.5 ± 0.7
17.6 ± 1.9
15.6 ± 3.1
0.8 ± 0.8
17 ± 3.1
17.7 ± 5.9
1.1 ± 1.2
1.00
0.64
1.00
1.00
0.86
0.26
0.34
1.00
0.82
Sinvals (mm)
Sinvals/BSA
Sinvals(Zscore)
20.4 ± 2.9
20.0 ± 3.1
-0.4 ± 0.7
21.9 ± 2.7
19.3 ± 3.5
-0.2 ± 0.7
22.8 ± 5.2
23.4 ± 7.2
0.73 ± 1.2
1.00
0.13
0.04
0.34
0.22
0.06
0.68
1.00
1.00
Sintubj (mm)
Sintubj/BSA
Sintubj(Z score)
17.9 ± 2.3
17.6 ± 3.0
0.4 ± 0.6
19.8 ± 2.6
17.4 ± 3.2
0.8 ± 0.7
19.6 ± 3.9
20.5 ± 7.6
1.2 ± 1.1
1.00
0.35
0.94
0.44
0.36
0.07
0.21
1.00
0.32
AscAo (mm)
AscAo/BSA
AscAo(Z score)
18.1 ± 2.1
17.8 ± 3.1
- 0.2 ± 0.8
21.0 ± 3.1
18.4 ± 3.4
1.2 ± 1.7
20.3 ± 4.8
21.1 ± 7.7
0.89 ± 1.9
1.00
0.57
1.00
0.31
0.27
0.18
0.04
1.00
0.02
PVAn (mm)
PVAn/BSA
PVAn (Z score)
17.2 ± 3.2
16.9 ± 3.4
-0.7 ± 0.9
19.5 ± 3.4
17.1 ± 3.7
- 0.3 ± 1.0
18.8 ± 4.3
19.9 ± 8.8
0.02 ± 1.5
1.00
0.70
0.79
0.94
0.53
1.00
0.27
1.00
0.38
MPA (mm)
MPA/BSA
MPA(Z score)
16.3 ± 2.1
16.3 ± 3.8
-1.1 ± 0.8
17.8 ± 3.2
15.7 ± 3.7
- 0.8 ± 1.0
19.5 ± 4.2
21.86±11.2
0.01 ± 0.95
0.63
0.08
0.15
0.04
0.10
0.07
0.51
1.00
1.00
LPA (mm)
LPA/BSA
LPA(Z score)
11.3 ± 1.5
11.6 ± 3.7
0.4 ± 1.2
13.3 ± 1.5
12.0 ± 3.5
1.3 ± 0.9
16.9 ± 4.7
17.7 ± 7
2.9 ± 1.3
0.01
0.02
0.01
0.08
0.06
0.1
0.09
1.00
0.15
RPA (mm)
RPA/BSA
RPA (Z score)
11.1 ± 1.4
11.2 ± 3.4
- 0.4 ± 1.0
14.0 ± 1.8
12.5 ± 3.4
0.5 ± 0.9
15.4 ± 2.1
16.5 ± 6.9
1.7 ± 1.1
0.20
0.12
0.06
0.09
0.08
0.2
0.01
1.00
0.02
TVmax 17.7±3.0 (16) 18.4±2.1 (10) 18 ± 2.9 1.00 1.00 1.00
LA/AO 1.5 ± 0.2 1.6 ± 0.2 1.8 ± 0.26 0.29 0.23 0.38
IVRT, ms 66.9±9.6 (17) 70.5±13.0 (13) 77.1 ± 20.4 0.84 0.26 1.00
IVRT, corrected 80.7±11.7 (11) 80.7±17.5 (9) 91.9 ± 23.4 0.45 0.17 1.00
CI 4.1±0.60 (9) 4.6 ± 1.0 4.8±1.2 (7) 1.00 0.98 0.71

LVIDd, left ventricular end diastolic dimension; LVISd, Left ventricular end systolic dimension; IVSd, interventricular septal dimension in diastole; LVPWd, left ventricular posterior wall dimension in diastole; EF, ejection fraction; SF, shortening fraction; AoAn, aortic valve annulus; Sinvals, sinus of valsalva; Sintubj, sinotubular junction; AscAo, ascending aorta; PVAn, pulmonary valve annulus; MPA, main pulmonary artery; LPA, left pulmonary artery; RPA, right pulmonary artery; TVmax, tricuspid valve regurgitation maximum peak velocity; LA/Ao, Left atrium aortic dimension ratio by M-mode; IVRT, Isovolumic relaxation time; CI, Cardiac index.

* Corrected for heart rate. P value is significant ≤ 0.05; significant values are highlighted in bald.